CLASS II Device recall · Reported 6 Jun 2018 · FDA Enforcement Report

HeartStart MRx Monitor/Defibrillator recalled

Philips Electronics North America is recalling HeartStart MRx Monitor/Defibrillator, distributed in North Carolina, Ohio. The recall was initiated on 3 May 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUS00588464, US00588657, US00589878, US00591080, US00593861
Quantity recalled5

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2035-2018
FDA event ID
79982
Recalling firm
Philips Electronics North America, Andover, MA
Classification
Class II
Status
Terminated
Recall initiated
3 May 2018
FDA classified
30 May 2018
Reported
6 Jun 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

3 May 2018Recall initiated by company
30 May 2018Classified by FDA+27 days
6 Jun 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component. Failure to charge could potentially cause therapy to be interrupted or delayed.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

HeartStart MRx Monitor/Defibrillator, Model No. M3535A (861288), M3536A (861289) Product Automated external defibrillators (non-wearable) Product Usage: The HeartStart MRx is for use for the termination of ventricular tachycardia and ventricular fibrillation. The device is for use by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac support, or defibrillation. It must be used by or on the order of a physician.

Where it was distributed

Worldwide Distribution to accounts in OH and NC. Foreign distribution to Lebanon.

North CarolinaOhio

Questions about this recall

Why was it recalled?

The MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component. Failure to charge could potentially cause therapy to be interrupted or delayed.

Which lots are affected?

US00588464, US00588657, US00589878, US00591080, US00593861

Where was it sold?

Worldwide Distribution to accounts in OH and NC. Foreign distribution to Lebanon.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Electronics North America

All 160

Other Pacemakers & Defibrillators recalls

All 494